Analystreport

ZIOPHARM Oncology Inc. (NASDAQ: ZIOP) was downgraded by analysts at JPMorgan Chase & Co. from a "neutral" rating to an "underweight" rating.

ZIOPHARM Oncology Inc  (ZIOP) 
Last ziopharm oncology inc earnings: 3/2 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.ziopharm.com